Matti Aapro

43.0k total citations · 7 hit papers
492 papers, 22.4k citations indexed

About

Matti Aapro is a scholar working on Oncology, Surgery and Physiology. According to data from OpenAlex, Matti Aapro has authored 492 papers receiving a total of 22.4k indexed citations (citations by other indexed papers that have themselves been cited), including 219 papers in Oncology, 148 papers in Surgery and 82 papers in Physiology. Recurrent topics in Matti Aapro's work include Nausea and vomiting management (131 papers), Cancer Treatment and Pharmacology (89 papers) and Anesthesia and Pain Management (79 papers). Matti Aapro is often cited by papers focused on Nausea and vomiting management (131 papers), Cancer Treatment and Pharmacology (89 papers) and Anesthesia and Pain Management (79 papers). Matti Aapro collaborates with scholars based in Switzerland, United States and Italy. Matti Aapro's co-authors include Jørn Herrstedt, Lazzaro Repetto, Martine Extermann, Stuart M. Lichtman, Peyman Hadji, Robert E. Coleman, Alex Molassiotis, S. Monfardini, Rudolph M. Navari and Paul J. Hesketh and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Matti Aapro

467 papers receiving 21.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

2010 777 citations Matti Aapro et al. European Journal of Cancer profile →
Use of comprehensive geriatric assessment in older cancer patients:

2005 770 citations Martine Extermann, Matti Aapro et al. Critical Reviews in Oncology/Hematology profile →
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

2016 444 citations Bernardo L. Rapoport, Matti Aapro et al. profile →
Bone health in cancer patients: ESMO Clinical Practice Guidelines

2014 401 citations Matti Aapro, Jørn Herrstedt et al. profile →
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

2016 397 citations Alex Molassiotis, Jørn Herrstedt et al. profile →
Bone health in cancer: ESMO Clinical Practice Guidelines

2020 294 citations Matti Aapro, Karin Jordan et al. profile →
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)

2021 157 citations Laura Biganzoli, Nicolò Matteo Luca Battisti et al. profile →

Peers

Countries citing papers authored by Matti Aapro

Since Specialization

Citations

This map shows the geographic impact of Matti Aapro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Aapro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Aapro more than expected).

Fields of papers citing papers by Matti Aapro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Aapro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Aapro. The network helps show where Matti Aapro may publish in the future.

Co-authorship network of co-authors of Matti Aapro

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Aapro. A scholar is included among the top collaborators of Matti Aapro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Aapro. Matti Aapro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting 2025 ·European Journal of Cancer ·Karin Jordan, Evandro de Azambuja, (unknown), Franziska Jahn, Mario Di Palma, Florian Scotté, Alex Molassiotis, Matti Aapro	1
2	Geriatric Assessment: ASCO Global Guideline 2025 ·JCO Global Oncology ·Cristiane Decat Bergerot, Sarah Temin, (unknown), Matti Aapro, Shabbir M.H. Alibhai, Zeba Aziz, (unknown), (unknown), Martine Extermann, Ravindran Kanesvaran, Bogda Koczwara, Kah Poh Loh, (unknown), (unknown), Vanita Noronha, Grant R. Williams, Enrique Soto‐Pérez‐de‐Celis	0
3	Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates 2025 ·Future Oncology ·Winnie Yeo, Giampaolo Bianchini, Javier Cortés, Luca Licata, María Vidal, Hirotoshi Iihara, Eric Roeland, Karin Jordan, Florian Scotté, Lee S. Schwartzberg, Rudolph M. Navari, Matti Aapro, Hope S. Rugo	0
4	From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development 2025 ·ESMO Open ·Stéphane Champiat, (unknown), Ariane Laparra, Andreas Charalambous, Mario Di Palma, Karin Jordan, Christophe Massard, Matti Aapro, (unknown)	0
5	Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence 2024 ·Critical Reviews in Oncology/Hematology ·Pere Gascón, Nadia Harbeck, Bernardo L. Rapoport, Ronald Anderson, (unknown), Sebastian Howe, Matti Aapro	0
6	Systematic nutritional screening and assessment in older patients: Rationale for its integration into oncology practice 2024 ·European Journal of Cancer ·Jürgen Bauer, (unknown), Rocco Barazzoni, Nicolò Matteo Luca Battisti, Enrique Soto‐Pérez‐de‐Celis, Marije E. Hamaker, Florian Scotté, Pierre Soubeyran, Matti Aapro	1
7	Opioid metabolism and drug-drug interaction in cancer 2024 ·The Oncologist ·Matti Aapro, Stefano Fogli, Bart Morlion, Romano Danesi	3
8	Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action 2023 ·Critical Reviews in Oncology/Hematology ·Jann Arends, (unknown), Stefan D. Anker, Riccardo A. Audisio, Rocco Barazzoni, Snežana Bošnjak, Paolo Bossi, (unknown), (unknown), Željko Krznarić, Florian Strasser, Matti Aapro	8
9	2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents 2023 ·Supportive Care in Cancer ·(unknown), Lee S. Schwartzberg, Hirotoshi Iihara, Matti Aapro, Richard J. Gralla, Paul J. Hesketh, Karin Jordan, Ronald Chow, Jørn Herrstedt	9
10	Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer 2023 ·Supportive Care in Cancer ·Matti Aapro, Stephen Chaplin, Paul Cornes, Sebastian Howe, Hartmut Link, (unknown), (unknown), Mario Di Palma, (unknown), (unknown)	4
11	IN34 OPTIMAL MANAGEMENT OF AN OLDER FRAIL PATIENT WITH ADVANCED BREAST CANCER 2023 ·The Breast ·Laura Biganzoli, Emanuela Risi, Elizabeth Bergsten-Nordström, Matti Aapro, Étienne Brain	0
12	Single‐dose NEPA versus an aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy 2023 ·Cancer Medicine ·Laurent Zelek, Rudolph M. Navari, Matti Aapro, Florian Scotté	8
13	Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life 2021 ·Patient Preference and Adherence ·Robert S. Epstein, Upal Kunal Basu Roy, Matti Aapro, Tehseen Salimi, (unknown), (unknown), (unknown), Cynthia J. Girman, Courtney Schlusser, Jeffrey Crawford	22
14	Implementing the European Code of Cancer Practice to Improve Europe’s Cancer Outcomes 2021 ·Mark Lawler, Kathy Oliver, (unknown), (unknown), (unknown), Matti Aapro, (unknown), (unknown), Richard Price, Peter J. Selby	0
15	Patient blood management in oncology in the Russian Federation: resolution to improve oncology care. 2020 ·SHILAP Revista de lepidopterología ·Axel Hofmann, Matti Aapro, (unknown), Е Б Жибурт, (unknown), (unknown), (unknown), Vladimir Lyadov, В. Моисеенко, (unknown), (unknown), Р. Ш. Хасанов, I V Poddubnaya	5
16	Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement 2013 ·The Breast ·Fátima Cardoso, Nuran Beşe, Sandra R. Distelhorst, José Luiz Barbosa Bevilacqua, Ophira Ginsburg, Steven M. Grunberg, Richard J. Gralla, (unknown), Olivia Pagani, Ann H. Partridge, Felícia Marie Knaul, Matti Aapro, Barbara L. Andersen, Beti Thompson, Julie R. Gralow, Benjamin O. Anderson	53
17	Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group 2008 ·European Journal of Cancer ·Eric Van Cutsem, Cornelius Van de Velde, Arnaud Roth, Florian Lordick, Claus‐Henning Köhne, Stefano Cascinu, Matti Aapro	76
18	September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents 2008 ·The Oncologist ·Matti Aapro, Hartmut Link	124
19	New paradigms in the treatment of advanced breast cancer: Introduction 1998 ·Seminars in Oncology ·Matti Aapro, Aron Goldhirsch	2
20	Cancer in the elderly : a nursing and medical perspective 1997 ·Elsevier eBooks ·(unknown), Matti Aapro	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact